Author: Multibagger News

Investment Manager’s Guide: Israeli Forces Kill 33 Palestinians in Gaza, Impact on Financial Markets | Nidal al-Mughrabi In the past 24 hours, Israeli forces have killed 33 Palestinians in Gaza amid battles with Hamas-led militants. Despite the violence, brief pauses in fighting allowed for a third day of polio vaccinations for children. The World Health Organization (WHO) reported that they are ahead of targets for vaccinations, despite the ongoing conflict. The Israeli military claimed to have killed eight Palestinian gunmen, including a senior Hamas commander. Meanwhile, Hamas and Islamic Jihad continued to battle Israeli forces in various areas of Gaza.…

Read More

Title: Exclusive: Halliburton Confirms Cyberattack, Data Breach by Ransomware Gang RansomHub Energy giant Halliburton has confirmed its systems were hacked and that intruders “accessed and exfiltrated information” following a cyberattack last week. In a brief filing with government regulators on Tuesday, Halliburton said it was “evaluating the nature and scope of the [stolen] information,” and what data breach notifications it is required to make. Halliburton last week said it took some of its systems offline following the detection of the cyberattack. The company now says it is “working to identify effects of the incident” on its ongoing oil and fracking…

Read More

Breaking News: Bitcoin Price Set to Surge Above $60,000 as Liquidity Clusters Signal Imminent Breakout As the world’s leading investment manager and financial market journalist, I have exclusive data indicating that Bitcoin is on the verge of a major price move. The liquidity heatmap shows a concentration of orders around the $60,000 mark, suggesting a potential catalyst for short-term volatility and a breakthrough past this crucial resistance level. Liquidity clusters like these often lead to increased market activity as traders reposition themselves, potentially driving prices sharply in either direction. The current market condition, characterized by a defined range and equal…

Read More

Wolfe Research has reaffirmed its Peerperform rating for Alnylam Pharmaceuticals (NASDAQ: ALNY) with a focus on the upcoming regulatory approval of its drug acoramidis, expected in November 2024. The firm predicts a stabilization in the stock’s performance until discussions intensify in the first quarter of 2025 regarding the market adoption of acoramidis. Following news from the European Society of Cardiology on August 30, Alnylam’s stock declined by 8%, contrasting with mixed reactions in the sector. Ionis Pharmaceuticals (NASDAQ: NASDAQ:) fell by 4%, while BridgeBio Pharma (NASDAQ:) saw a 13% increase. The analyst suggests that Alnylam’s market activity will likely remain…

Read More

Google Faces Second Antitrust Trial: What Investors Need to Know Google is set to face its second antitrust trial next week in a Virginia district court, raising eyebrows but not alarms among investors. Unlike the ongoing search trial, Barclays analysts suggest that this new trial should not be a significant concern for Google’s financial health, aside from potential headline risks. The Financial Impact: Minimal at Best The crux of the matter involves Google’s advertising technology stack, which constitutes less than 5% of the company’s gross profit. Specifically, the area under scrutiny represents a mere 1% of Google’s gross profit. This…

Read More

Riad Salameh, Former Lebanon Central Bank Governor, Arrested on Financial Crimes Charges In a stunning turn of events, Lebanon’s former central bank governor, Riad Salameh, was arrested on Tuesday following a judicial hearing in Beirut. Salameh has been charged with a range of financial crimes, including money-laundering, embezzlement, and illicit enrichment. Despite denying any wrongdoing, he now finds himself in the midst of a legal battle that could have far-reaching implications. The charges against Salameh stem from his alleged involvement with Optimum Invest, a Lebanese firm that offers income brokerage services. It is believed that Optimum had dealings with Lebanon’s…

Read More

Deadly Russian Missile Strike Kills 41 in Ukraine’s Poltava – President Zelenskiy Orders Investigation By Olena Harmash KYIV (Multibagger) – At least 41 people were killed and more than 180 wounded on Tuesday when Russia struck a military institute in the central town of Poltava with two missiles, President Volodymyr Zelenskiy said, the war’s deadliest single attack so far this year. Zelenskiy said in a video that Russian forces struck with two ballistic missiles, damaging a building of the Military Institute of Communications. He ordered a full and prompt investigation. “The Russian scum will definitely be held accountable for this…

Read More

PruVen Capital, Founded by Former Benchmark and Citi Ventures VC Ramneek Gupta, Closes $378.5M Fund II for Financial and Enterprise Startups PruVen Capital, a prominent fintech and insurance tech venture fund led by the illustrious former Benchmark and Citi Ventures VC Ramneek Gupta, has successfully closed a new $378.5 million Fund II. This fund will be utilized to invest in financial services and enterprise-focused startups, aiming to revolutionize the industry. What sets this second fund apart is Gupta’s expansion of partnerships beyond a single corporate funder to include various financial and insurance LPs. While Prudential Financial remains the lead investor,…

Read More

Atai Life Sciences (NASDAQ:ATAI) Receives Buy Rating and $15 Price Target from H.C. Wainwright Post Corporate Update Atai Life Sciences N.V. (NASDAQ:ATAI) received a reaffirmed Buy rating and $15.00 price target from H.C. Wainwright following a corporate update. The update highlighted the advancement of atai’s pipeline, with several significant milestones expected in the coming years. Key highlights include: – BPL-003, an intranasal psychedelic treatment for depression, expected to complete enrollment for Phase 2b trial in the second half of 2024. – VLS-01, a DMT-based treatment, set to progress to Phase 2 trials by the end of 2024 after positive Phase…

Read More

Investing.com – The U.S. dollar remained stable on Tuesday as investors eagerly anticipate the release of crucial economic data, specifically Friday’s U.S. payrolls report. This data could solidify expectations for an interest rate cut from the Federal Reserve later this month. At 04:05 ET (09:05 GMT), the Dollar Index, which monitors the dollar against a basket of other currencies, traded around 101.617, staying close to Monday’s two-week high of 101.79. In August, the index saw a 2.2% decline due to anticipations of U.S. rate cuts. Dollar Focuses on Labor Market The U.S. will be releasing key economic indicators this week,…

Read More